Only LINC01615 was significantly correlated with the survival prognosis of breast cancer patients, and the prognosis of patients with upregulated LINC01615 expression was significantly lower than that with low LINC01615 expression (Figure S3). This evidence concerns the gene LINC01615 and breast cancer.